Global Aneurysm Coiling and Embolization Devices Market Size By Type (Embolization Coils, Balloon and Stent-Assisted Coils), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023...

The Global Aneurysm Coiling and Embolization Devices Market was valued at USD 1.4 billion in 2023 and is projected to reach USD 2.8 billion by 2031, growing at a CAGR of 9.1% from 2023 to 2031. The rising incidence of cerebral aneurysms, increasing preference for minimally invasive procedures, and advancements in neurointerventional technology are the primary drivers fueling market growth. Aneurysm coiling and embolization devices are critical in preventing hemorrhagic strokes and are widely used in treating both ruptured and unruptured intracranial aneurysms.

Drivers:

1. Rising Incidence of Intracranial Aneurysms:

The increasing detection rate of brain aneurysms due to widespread use of advanced imaging techniques is significantly boosting demand for coiling and embolization procedures.

2. Growing Demand for Minimally Invasive Neurosurgery:

Patients and healthcare providers are shifting towards endovascular techniques due to their reduced recovery time, minimal complications, and lower cost compared to open surgeries.

3. Technological Advancements in Embolization Devices:

Development of next-generation detachable coils, bioactive materials, and flow-diverting stents is enhancing procedural safety and effectiveness, expanding clinical adoption globally.

Restraints:

1. High Cost of Treatment and Devices:

The advanced nature of these neurointerventional tools comes with a high price tag, which can be a barrier to widespread adoption, especially in low-income regions.

2. Procedural Complications and Risks:

Despite being minimally invasive, risks such as coil migration, incomplete occlusion, and recurrence may deter certain patients or clinicians from opting for these procedures.

Opportunity:

1. Expansion into Emerging Healthcare Markets:

Rising healthcare infrastructure investments in Asia-Pacific, Latin America, and the Middle East present untapped opportunities for market players.

2. Integration with AI-based Imaging and Robotics:

Emerging technologies such as AI-enhanced neuroimaging and robot-assisted endovascular surgery are expected to revolutionize aneurysm treatment pathways, offering future growth potential.

Market by System Type Insights:

Detachable Coils held the largest share of the market in 2023, favored for their flexibility and retrievability during aneurysm occlusion. However, the Flow Diverters segment is expected to witness the fastest growth during the forecast period, driven by increasing applications in complex and wide-neck aneurysms.

Market by End-use Insights:

Hospitals remained the dominant end-user segment in 2023, accounting for over 60% of the market share, due to the availability of advanced neurovascular equipment and skilled neurosurgeons. Ambulatory Surgical Centers (ASCs) are projected to grow rapidly as they increasingly adopt neurointerventional procedures owing to shorter wait times and reduced costs.

Market by Regional Insights:

North America led the global market in 2023, driven by a high prevalence of brain aneurysms, favorable reimbursement policies, and the presence of leading device manufacturers. Meanwhile, Asia-Pacific is poised to register the highest CAGR during the forecast period, propelled by improving healthcare access and rising awareness about neurovascular diseases in countries like India and China.

Competitive Scenario:

Key players in the Global Aneurysm Coiling and Embolization Devices Market include Stryker Corporation, Medtronic plc, Johnson & Johnson (Cerenovus), MicroVention Inc. (Terumo Corporation), Penumbra Inc., and Balt USA LLC. These companies are investing in R&D, FDA approvals, and strategic acquisitions to expand their product portfolios and geographic reach.

Key Developments:

In 2024, Medtronic launched its new generation flow diverter with enhanced conformability for complex aneurysm cases.

Stryker acquired a U.S.-based start-up in 2023 to integrate AI-based imaging into its neurovascular platform.

In 2022, Penumbra received regulatory clearance in Europe for its new embolization coil system designed for high-precision aneurysm occlusion.

Scope of Work – Global Aneurysm Coiling and Embolization Devices Market

Report Metric Details

Market Size (2023) USD 1.4 Billion

Projected Market Size (2031) USD 2.8 Billion

CAGR (2023–2031) 9.1%

Market Segments By System Type (Detachable Coils, Flow Diverters, Liquid Embolics), By End-use (Hospitals, ASCs)

Growth Drivers Rising incidence of aneurysms, shift to minimally invasive procedures, tech advancements

Opportunities Growth in emerging markets, integration with AI and robotics

FAQs

1. What is the current market size of the Global Aneurysm Coiling and Embolization Devices Market?

The market was valued at USD 1.4 billion in 2023.

2. What is the major growth driver of the Global Aneurysm Coiling and Embolization Devices Market?

The shift towards minimally invasive neurosurgery and rising incidence of brain aneurysms are key growth drivers.

3. Which is the largest region during the forecast period in the Global Aneurysm Coiling and Embolization Devices Market?